189 related articles for article (PubMed ID: 20679621)
1. Fatty acid synthase polymorphisms, tumor expression, body mass index, prostate cancer risk, and survival.
Nguyen PL; Ma J; Chavarro JE; Freedman ML; Lis R; Fedele G; Fiore C; Qiu W; Fiorentino M; Finn S; Penney KL; Eisenstein A; Schumacher FR; Mucci LA; Stampfer MJ; Giovannucci E; Loda M
J Clin Oncol; 2010 Sep; 28(25):3958-64. PubMed ID: 20679621
[TBL] [Abstract][Full Text] [Related]
2. P300 acetyltransferase regulates fatty acid synthase expression, lipid metabolism and prostate cancer growth.
Gang X; Yang Y; Zhong J; Jiang K; Pan Y; Karnes RJ; Zhang J; Xu W; Wang G; Huang H
Oncotarget; 2016 Mar; 7(12):15135-49. PubMed ID: 26934656
[TBL] [Abstract][Full Text] [Related]
3. Association of fatty-acid synthase polymorphisms and expression with outcomes after radical prostatectomy.
Cheng J; Ondracek RP; Mehedint DC; Kasza KA; Xu B; Gill S; Azabdaftari G; Yao S; Morrison CD; Mohler JL; Marshall JR
Prostate Cancer Prostatic Dis; 2015 Jun; 18(2):182-9. PubMed ID: 25868764
[TBL] [Abstract][Full Text] [Related]
4. Selenoprotein P genetic variants and mrna expression, circulating selenium, and prostate cancer risk and survival.
Penney KL; Li H; Mucci LA; Loda M; Sesso HD; Stampfer MJ; Ma J
Prostate; 2013 May; 73(7):700-5. PubMed ID: 23129481
[TBL] [Abstract][Full Text] [Related]
5. Cohort study of fatty acid synthase expression and patient survival in colon cancer.
Ogino S; Nosho K; Meyerhardt JA; Kirkner GJ; Chan AT; Kawasaki T; Giovannucci EL; Loda M; Fuchs CS
J Clin Oncol; 2008 Dec; 26(35):5713-20. PubMed ID: 18955444
[TBL] [Abstract][Full Text] [Related]
6. Confirmation of genetic variants associated with lethal prostate cancer in a cohort of men from hereditary prostate cancer families.
Karyadi DM; Zhao S; He Q; McIntosh L; Wright JL; Ostrander EA; Feng Z; Stanford JL
Int J Cancer; 2015 May; 136(9):2166-71. PubMed ID: 25273821
[TBL] [Abstract][Full Text] [Related]
7. Common genetic variation of the calcium-sensing receptor and lethal prostate cancer risk.
Shui IM; Mucci LA; Wilson KM; Kraft P; Penney KL; Stampfer MJ; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2013 Jan; 22(1):118-26. PubMed ID: 23125333
[TBL] [Abstract][Full Text] [Related]
8. Body mass index and risk of colorectal cancer according to fatty acid synthase expression in the nurses' health study.
Kuchiba A; Morikawa T; Yamauchi M; Imamura Y; Liao X; Chan AT; Meyerhardt JA; Giovannucci E; Fuchs CS; Ogino S
J Natl Cancer Inst; 2012 Mar; 104(5):415-20. PubMed ID: 22312135
[TBL] [Abstract][Full Text] [Related]
9. A large prospective study of SEP15 genetic variation, interaction with plasma selenium levels, and prostate cancer risk and survival.
Penney KL; Schumacher FR; Li H; Kraft P; Morris JS; Kurth T; Mucci LA; Hunter DJ; Kantoff PW; Stampfer MJ; Ma J
Cancer Prev Res (Phila); 2010 May; 3(5):604-10. PubMed ID: 20424130
[TBL] [Abstract][Full Text] [Related]
10. FASN Gene Methylation is Associated with Fatty Acid Synthase Expression and Clinical-genomic Features of Prostate Cancer.
Dairo O; DePaula Oliveira L; Schaffer E; Vidotto T; Mendes AA; Lu J; Huynh SV; Hicks J; Sowalsky AG; De Marzo AM; Joshu CE; Hanratty B; Sfanos KS; Isaacs WB; Haffner MC; Lotan TL
Cancer Res Commun; 2024 Jan; 4(1):152-163. PubMed ID: 38112617
[TBL] [Abstract][Full Text] [Related]
11. Val1483Ile in FASN gene is linked to central obesity and insulin sensitivity in adult white men.
Moreno-Navarrete JM; Botas P; Valdés S; Ortega FJ; Delgado E; Vázquez-Martín A; Bassols J; Pardo G; Ricart W; Menéndez JA; Fernández-Real JM
Obesity (Silver Spring); 2009 Sep; 17(9):1755-61. PubMed ID: 19300427
[TBL] [Abstract][Full Text] [Related]
12. Caveolin-1 is required for the upregulation of fatty acid synthase (FASN), a tumor promoter, during prostate cancer progression.
Di Vizio D; Sotgia F; Williams TM; Hassan GS; Capozza F; Frank PG; Pestell RG; Loda M; Freeman MR; Lisanti MP
Cancer Biol Ther; 2007 Aug; 6(8):1263-8. PubMed ID: 17786030
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in oxidative stress pathway genes and prostate cancer risk.
Zhang Z; Jiang D; Wang C; Garzotto M; Kopp R; Wilmot B; Thuillier P; Dang A; Palma A; Farris PE; Shannon J
Cancer Causes Control; 2019 Dec; 30(12):1365-1375. PubMed ID: 31667711
[TBL] [Abstract][Full Text] [Related]
14. Caveolin-1 interacts with a lipid raft-associated population of fatty acid synthase.
Di Vizio D; Adam RM; Kim J; Kim R; Sotgia F; Williams T; Demichelis F; Solomon KR; Loda M; Rubin MA; Lisanti MP; Freeman MR
Cell Cycle; 2008 Jul; 7(14):2257-67. PubMed ID: 18635971
[TBL] [Abstract][Full Text] [Related]
15. Height, body mass index and prostate cancer risk and mortality by way of detection and cancer risk category.
Jochems SHJ; Stattin P; Häggström C; Järvholm B; Orho-Melander M; Wood AM; Stocks T
Int J Cancer; 2020 Dec; 147(12):3328-3338. PubMed ID: 32525555
[TBL] [Abstract][Full Text] [Related]
16. Speckle-type POZ protein suppresses lipid accumulation and prostate cancer growth by stabilizing fatty acid synthase.
Gang X; Xuan L; Zhao X; Lv Y; Li F; Wang Y; Wang G
Prostate; 2019 Jun; 79(8):864-871. PubMed ID: 30955223
[TBL] [Abstract][Full Text] [Related]
17. Single-nucleotide polymorphisms in DNMT3B gene and DNMT3B mRNA expression in association with prostate cancer mortality.
Zelic R; Fiano V; Ebot EM; Coseo Markt S; Grasso C; Trevisan M; De Marco L; Delsedime L; Zugna D; Mucci LA; Richiardi L
Prostate Cancer Prostatic Dis; 2019 May; 22(2):284-291. PubMed ID: 30341411
[TBL] [Abstract][Full Text] [Related]
18. Destabilization of Fatty Acid Synthase by Acetylation Inhibits De Novo Lipogenesis and Tumor Cell Growth.
Lin HP; Cheng ZL; He RY; Song L; Tian MX; Zhou LS; Groh BS; Liu WR; Ji MB; Ding C; Shi YH; Guan KL; Ye D; Xiong Y
Cancer Res; 2016 Dec; 76(23):6924-6936. PubMed ID: 27758890
[TBL] [Abstract][Full Text] [Related]
19. Association Between the Body Mass Index and Prostate Cancer at Biopsy is Modified by Genetic Risk: A Cross-Sectional Analysis in China.
Zhang GM; Zhu Y; Chen HT; Han CT; Liu F; Xu JF; Ye DW
Medicine (Baltimore); 2015 Oct; 94(42):e1603. PubMed ID: 26496266
[TBL] [Abstract][Full Text] [Related]
20. Association of CASP3 genetic polymorphisms rs1049216, rs2705897 and rs4647603 with the risk of prostate cancer in Galicia (NW Spain).
López-Trigo N; Aguín N; Castuera IP; Rodríguez-Alonso A; Luis JR; Caeiro B
Gene; 2018 Dec; 679():126-132. PubMed ID: 30176316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
